Mucosal AIDS vaccines: current status and future directions.
about
Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa.A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisationsImpact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.Problems and emerging approaches in HIV/AIDS vaccine development.Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.Differential immunogenicity of vaccinia and HIV-1 components of a human recombinant vaccine in mucosal and blood compartments.Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.Adjuvants and delivery systems in veterinary vaccinology: current state and future developments.Localized cyclical variations in immunoproteins in the female genital tract and the implications on the design and assessment of mucosal infection and therapies.Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells.
P2860
Q30387447-B371F428-8761-4DD8-A75B-3418D23682B9Q33593103-598D36FE-FD6C-463D-8870-A38BAFB73162Q35575565-49E11F27-DD99-4B54-8960-CA13CBB1EC88Q35628697-287A5A48-4813-40DF-8094-7F3C37B27B46Q35849596-05CFDC83-043E-4219-A725-F9B8087A4AB5Q36663607-2BE50FF6-B137-437F-86B9-F29279B5EB6DQ36758574-A8126F14-D464-4E1E-98CB-CE22EEFDC197Q36844746-81C2ADBB-617D-4B9A-8225-B092DECFC9BBQ36943319-A473717C-983C-4E67-934F-E1F551608CE7Q37590335-3CC70507-4338-4A1D-B9B0-E45CC7032BE2Q37822316-C097F737-0CFA-4AFA-BBF2-0F120BCB0F4CQ47246184-812F9A9B-27FC-479E-8E78-2E96639D0B1CQ50991984-D13B9CA1-716B-4F4D-BB91-C04A877CC90A
P2860
Mucosal AIDS vaccines: current status and future directions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mucosal AIDS vaccines: current status and future directions.
@ast
Mucosal AIDS vaccines: current status and future directions.
@en
type
label
Mucosal AIDS vaccines: current status and future directions.
@ast
Mucosal AIDS vaccines: current status and future directions.
@en
prefLabel
Mucosal AIDS vaccines: current status and future directions.
@ast
Mucosal AIDS vaccines: current status and future directions.
@en
P2093
P2860
P356
P1476
Mucosal AIDS vaccines: current status and future directions.
@en
P2093
Igor M Belyakov
Jay A Berzofsky
Jeffrey D Ahlers
P2860
P304
P356
10.1586/14760584.3.4.S65
P433
P577
2004-08-01T00:00:00Z